Full Text View
Tabular View
No Study Results Posted
Related Studies
Multi-center, Open Label, Extension Study of ALN-VSP02 in Cancer Patients Who Have Responded to ALN-VSP02 Treatment
This study has been completed.
Study NCT01158079   Information provided by Alnylam Pharmaceuticals

First Received on December 11, 2009.   Last Updated on October 11, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interventions listed in this trial
Sponsors listed in this trial